Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Tata India Pharma & Healthcare Fund-Regular Plan-Growth -3.36 -1.74 27.23 20.49 25.50 12.78
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
NIFTY PHARMA - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 27.23 20.49 25.50 2.13 1,287.45
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 21.35 19.23 25.77 1.80 8,914.89
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 34.34 23.90 28.58 1.91 5,320.29
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 29.60 22.95 27.55 1.94 3,628.03
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 31.20 21.89 27.95 1.90 3,339.79
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 26.95 17.64 26.57 1.92 2,863.52

Fund Holdings as on 31-December-2024

  • SUN PHARMACEUTICAL INDUSTRIES LTD

  • AUROBINDO PHARMA LTD

  • LUPIN LTD

  • DR REDDYS LABORATORIES LTD

  • CIPLA LTD

  • DIVI LABORATORIES LTD

  • FORTIS HEALTHCARE LTD

  • CASH / NET CURRENT ASSET

  • ZYDUS LIFESCIENCES LTD

  • APOLLO HOSPITALS ENTERPRISE LTD

  • ALKEM LABORATORIES LTD

  • WOCKHARDT LTD

  • ASTER DM HEALTHCARE LTD

  • ORCHID PHARMA LTD

  • LAURUS LABS LTD

  • AJANTA PHARMA LTD

  • HEALTHCARE GLOBAL ENTERPRISES LTD

  • IPCA LABORATORIES LTD

  • MEDI ASSIST HEALTHCARE SERVICES LTD

  • TORRENT PHARMACEUTICALS LTD

  • FDC LTD

  • INDOCO REMEDIES LTD

  • JUPITER LIFE LINE HOSPITALS LTD

  • AKUMS DRUGS AND PHARMACEUTICALS LTD

  • PIRAMAL PHARMA LTD

  • MANKIND PHARMA LTD

  • SANOFI INDIA LTD

  • COROMANDEL INTERNATIONAL LTD

  • AMI ORGANICS LTD

  • MEDPLUS HEALTH SERVICES LTD

  • SANOFI CONSUMER HEALTHCARE INDIA LTD

  • SYNGENE INTERNATIONAL LTD

  • PROCTER & GAMBLE HEALTH LTD

  • INVENTURUS KNOWLEDGE SOLUTIONS LTD

  • GLAXOSMITHKLINE PHARMACEUTICALS LTD

  • DEEPAK NITRITE LTD

  • A) REPO

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Business Support

  • Fertilizers

  • BPO/ITeS

  • Chemicals

View More

About Tata India Pharma & Healthcare Fund

Scheme Analysis

Tata India Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Tata Mutual Fund. It was launched on 28-Dec-2015 and currently has an AUM of ₹1,287.45 crore. Tata India Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and NIFTY PHARMA - TRI as secondary index.

The NAV of Tata India Pharma & Healthcare Fund ended up ₹0.39(1.29%)yesterday to ₹30.1672.

Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD, and

The Tata India Pharma & Healthcare Fund is managed by Meeta Shetty and Rajat Srivastava.

Fund House Contact

1903, B Wing, Parinee Crescenzo, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051

022 6282 7777
service@tataamc.com
+91 (22) 22613782